Wolverine Asset Management LLC lifted its holdings in M3-Brigade Acquisition V Corp. (NASDAQ:MBAV – Free Report) by 258.3% during the third quarter, Holdings Channel.com reports. The institutional investor owned 350,157 shares of the company’s stock after acquiring an additional 252,419 shares during the quarter. Wolverine Asset Management LLC’s holdings in M3-Brigade Acquisition V were worth $3,694,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other institutional investors and hedge funds also recently modified their holdings of the business. Sandia Investment Management LP bought a new stake in M3-Brigade Acquisition V during the second quarter worth $334,000. Clear Street LLC increased its position in shares of M3-Brigade Acquisition V by 2,280.8% during the 2nd quarter. Clear Street LLC now owns 32,069 shares of the company’s stock valued at $362,000 after purchasing an additional 30,722 shares during the last quarter. Tuttle Capital Management LLC purchased a new stake in shares of M3-Brigade Acquisition V during the 2nd quarter valued at $437,000. Levin Capital Strategies L.P. bought a new stake in shares of M3-Brigade Acquisition V during the 2nd quarter worth $538,000. Finally, Bluefin Capital Management LLC purchased a new position in shares of M3-Brigade Acquisition V in the 2nd quarter worth about $690,000.
Insider Activity at M3-Brigade Acquisition V
In other M3-Brigade Acquisition V news, major shareholder Fitzgerald & Co. Cantor acquired 3,529,081 shares of the business’s stock in a transaction that occurred on Wednesday, December 17th. The stock was bought at an average cost of $10.80 per share, with a total value of $38,114,074.80. Following the acquisition, the insider owned 7,779,865 shares in the company, valued at approximately $84,022,542. This represents a 83.02% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is accessible through the SEC website.
M3-Brigade Acquisition V Stock Performance
Analysts Set New Price Targets
Separately, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of M3-Brigade Acquisition V in a research report on Monday, December 22nd. One research analyst has rated the stock with a Sell rating, According to MarketBeat.com, M3-Brigade Acquisition V presently has a consensus rating of “Sell”.
Check Out Our Latest Report on M3-Brigade Acquisition V
About M3-Brigade Acquisition V
M3-Brigade Acquisition V is a special purpose acquisition company (SPAC) sponsored by M3 Inc, a global healthcare information and technology provider, and Brigade Capital Management, an investment management firm. The company is structured as a blank‐check vehicle listed on the Nasdaq Stock Market under the ticker MBAV, with the objective of identifying and completing a business combination in the healthcare, life sciences or related sectors.
The company benefits from the operational expertise of M3’s digital health platform and real‐world data capabilities, combined with Brigade’s deep experience in credit and asset management.
Read More
- Five stocks we like better than M3-Brigade Acquisition V
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- How a Family Trust May Be Able To Help Preserve Your Wealth
- A U.S. “birthright” claim worth trillions – activated quietly
- Executive Order 14330: Trump’s Biggest Yet
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
Want to see what other hedge funds are holding MBAV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for M3-Brigade Acquisition V Corp. (NASDAQ:MBAV – Free Report).
Receive News & Ratings for M3-Brigade Acquisition V Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for M3-Brigade Acquisition V and related companies with MarketBeat.com's FREE daily email newsletter.
